Meier P, Ferguson D J, Karrison T
Department of Statistics, University of Chicago, IL 60637.
Cancer. 1989 Jan 1;63(1):188-95. doi: 10.1002/1097-0142(19890101)63:1<188::aid-cncr2820630130>3.0.co;2-m.
In view of increasing debate over possible benefit of more complete surgery compared to conservative procedures, a randomized controlled trial contrasting the then standard Halsted radical (RDL) operation with the more complete extended radical (EXT) mastectomy was initiated in 1973. Between November 1973 and July 1982, 123 women younger than 70 years of age and at clinical Stages I and II were enrolled. Of the total series, 112 were treated by the same surgeon and confirmed pathologically as having invasive mammary carcinoma. In this more homogeneous subgroup, the 10-year survival rates (and standard errors) were for RDL, 60% (+/- 7%) and for EXT, 74% (+/- 6%) (P value for comparison of survival curves = 0.13). In patients from this subgroup with central-medial tumors, comprising 62% of the total, survival after RDL at 10 years was 60% (+/- 8%), and after EXT 86% (+/- 6%) (P = 0.025). In the remaining patients with lateral tumors, survival rates were unaffected by treatment: 58% (+/- 13%) and 56% (+/- 11%), respectively (P = 0.62). Comparison of a nonrandomized series of 266 RDL and 124 EXT patients treated between 1960 and 1978 found differences consistent with those of the randomized study, although not statistically significant.
鉴于对于更彻底的手术与保守手术相比可能带来的益处存在越来越多的争论,1973年启动了一项随机对照试验,对比当时的标准Halsted根治术(RDL)与更彻底的扩大根治术(EXT)乳房切除术。1973年11月至1982年7月,纳入了123名年龄小于70岁、临床分期为I期和II期的女性。在整个系列中,112名患者由同一位外科医生治疗,并经病理证实患有浸润性乳腺癌。在这个更具同质性的亚组中,RDL组的10年生存率(及标准误)为60%(±7%),EXT组为74%(±6%)(生存曲线比较的P值 = 0.13)。在该亚组中,中央内侧肿瘤患者占总数的62%,RDL术后10年生存率为60%(±8%),EXT术后为86%(±6%)(P = 0.025)。在其余外侧肿瘤患者中,生存率不受治疗影响:分别为58%(±13%)和56%(±11%)(P = 0.62)。对1960年至1978年间治疗的266例RDL患者和124例EXT患者的非随机系列进行比较,发现差异与随机研究一致,尽管无统计学意义。